Global Gene Expression Market Growth, Size, Trends Analysis - By Product, By Technique, By Process, By Application - Regional Outlook, Competitive Strategies and Segment Forecast to 2034

Description

Gene Expression Market Introduction and Overview

According to SPER market research, 'Global Gene Expression Market Size- By Product, By Technique, By Process, By Application - Regional Outlook, Competitive Strategies and Segment Forecast to 2034' state that the Global Gene Expression Market is predicted to reach 25.9 billion by 2034 with a CAGR of 5.26%.

Gene expression is the process by which a gene's information is used to synthesise a functioning gene product, such as a protein or RNA molecule. These compounds are frequently required for the cell to function normally. During gene expression, a gene's DNA sequence is replicated into a complementary RNA sequence, which is then used to control the manufacture of the matching protein or RNA molecule.

Restraints: The rising costs of instruments and consumables in gene expression analysis create significant challenges for research and healthcare institutions. Complex technologies like microarrays and next-generation sequencing require advanced engineering and expensive reagents for RNA work, leading to high initial costs. Additionally, continuous research and development investments are needed to improve these technologies.

Scope of the report:

Report Metric Details

Market size available for years 2021-2034

Base year considered 2024

Forecast period 2025-2034

Segments covered By Product, By Technique, By Process, By Application

Regions covered

North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa

Companies Covered

QIAGEN, Quest Diagnostics, Inc, F. Hoffmann-La Roche Ltd, Illumina, Inc, PerkinElmer, Inc, Bio-Rad Laboratories, Thermo Fisher Scientific, Inc, Agilent Technologies, GE Healthcare, Danaher Corp.

Global Gene Expression Market Segmentation:

By Product: Based on the Product, Global Gene Expression Market is segmented as; Kits & Reagents, DNA Chips, Others.

By Technique: Based on the Technique, Global Gene Expression Market is segmented as; RNA Expression, Promoter Analysis, Protein Expression & Posttranslational Modification Analysis.

By Process: Based on the Process, Global Gene Expression Market is segmented as; Sample Collection, Purification, cDNA synthesis & conversion, PCR Analysis, Data analysis & interpretation.

By Application: Based on the Application, Global Gene Expression Market is segmented as; Drug Discovery & Development, Clinical Diagnostics, Biotech & Microbiology, Others.

By Region: This research also includes data for North America, Latin America, Asia-Pacific, Europe, Middle East & Africa.

Product Code: HLCA25190

1.Introduction

1.1.Scope of the report
1.2.Market segment analysis

2.Research Methodology

2.1.Research data source
- 2.1.1.Secondary Data
- 2.1.2.Primary Data
- 2.1.3.SPERs internal database
- 2.1.4.Premium insight from KOLs
2.2.Market size estimation
- 2.2.1.Top-down and Bottom-up approach
2.3.Data triangulation

3.Executive Summary

4.Market Dynamics

4.1.Driver, Restraint, Opportunity and Challenges analysis
- 4.1.1.Drivers
- 4.1.2.Restraints
- 4.1.3.Opportunities
- 4.1.4.Challenges

5.Market variable and outlook

5.1.SWOT Analysis
- 5.1.1.Strengths
- 5.1.2.Weaknesses
- 5.1.3.Opportunities
- 5.1.4.Threats
5.2.PESTEL Analysis
- 5.2.1.Political Landscape
- 5.2.2.Economic Landscape
- 5.2.3.Social Landscape
- 5.2.4.Technological Landscape
- 5.2.5.Environmental Landscape
- 5.2.6.Legal Landscape
5.3.PORTERs Five Forces
- 5.3.1.Bargaining power of suppliers
- 5.3.2.Bargaining power of buyers
- 5.3.3.Threat of Substitute
- 5.3.4.Threat of new entrant
- 5.3.5.Competitive rivalry
5.4.Heat Map Analysis

6.Competitive Landscape

6.1.Global Gene Expression Market Manufacturing Base Distribution, Sales Area, Product Type
6.2.Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Gene Expression Market

7.Global Gene Expression Market, By Product (USD Million) 2021-2034

7.1.Kits & Reagents
7.2.DNA Chips
7.3.Others

8.Global Gene Expression Market, By Technique (USD Million) 2021-2034

8.1.RNA Expression
8.2.Promoter Analysis
8.3.Protein Expression & Posttranslational Modification Analysis

9.Global Gene Expression Market, By Process (USD Million) 2021-2034

9.1.Sample Collection
9.2.Purification
9.3.cDNA synthesis & conversion
9.4.PCR Analysis
9.5.Data analysis & interpretation

10.Global Gene Expression Market, By Application (USD Million) 2021-2034

10.1.Drug Discovery & Development
10.2.Clinical Diagnostics
10.3.Biotech & Microbiology
10.4.Others

11.Global Gene Expression Market, (USD Million) 2021-2034

11.1.Global Gene Expression Market Size and Market Share

12.Global Gene Expression Market, By Region, (USD Million) 2021-2034

12.1.Asia-Pacific
- 12.1.1.Australia
- 12.1.2.China
- 12.1.3.India
- 12.1.4.Japan
- 12.1.5.South Korea
- 12.1.6.Rest of Asia-Pacific
12.2.Europe
- 12.2.1.France
- 12.2.2.Germany
- 12.2.3.Italy
- 12.2.4.Spain
- 12.2.5.United Kingdom
- 12.2.6.Rest of Europe
12.3.Middle East and Africa
- 12.3.1.Kingdom of Saudi Arabia
- 12.3.2.United Arab Emirates
- 12.3.3.Qatar
- 12.3.4.South Africa
- 12.3.5.Egypt
- 12.3.6.Morocco
- 12.3.7.Nigeria
- 12.3.8.Rest of Middle-East and Africa
12.4.North America
- 12.4.1.Canada
- 12.4.2.Mexico
- 12.4.3.United States
12.5.Latin America
- 12.5.1.Argentina
- 12.5.2.Brazil
- 12.5.3.Rest of Latin America

13.Company Profile

13.1.Catalent Inc
- 13.1.1.Company details
- 13.1.2.Financial outlook
- 13.1.3.Product summary
- 13.1.4.Recent developments
13.2.QIAGEN
- 13.2.1.Company details
- 13.2.2.Financial outlook
- 13.2.3.Product summary
- 13.2.4.Recent developments
13.3.Quest Diagnostics, Inc
- 13.3.1.Company details
- 13.3.2.Financial outlook
- 13.3.3.Product summary
- 13.3.4.Recent developments
13.4.F. Hoffmann-La Roche Ltd
- 13.4.1.Company details
- 13.4.2.Financial outlook
- 13.4.3.Product summary
- 13.4.4.Recent developments
13.5.Illumina, Inc
- 13.5.1.Company details
- 13.5.2.Financial outlook
- 13.5.3.Product summary
- 13.5.4.Recent developments
13.6.PerkinElmer, Inc
- 13.6.1.Company details
- 13.6.2.Financial outlook
- 13.6.3.Product summary
- 13.6.4.Recent developments
13.7.Bio-Rad Laboratories
- 13.7.1.Company details
- 13.7.2.Financial outlook
- 13.7.3.Product summary
- 13.7.4.Recent developments
13.8.Thermo Fisher Scientific, Inc
- 13.8.1.Company details
- 13.8.2.Financial outlook
- 13.8.3.Product summary
- 13.8.4.Recent developments
13.9.Agilent Technologies
- 13.9.1.Company details
- 13.9.2.Financial outlook
- 13.9.3.Product summary
- 13.9.4.Recent developments
13.10.GE Healthcare
- 13.10.1.Company details
- 13.10.2.Financial outlook
- 13.10.3.Product summary
- 13.10.4.Recent developments
13.11.Danaher Corp.
- 13.11.1.Company details
- 13.11.2.Financial outlook
- 13.11.3.Product summary
- 13.11.4.Recent developments
13.12.Others